The desperation has really increased as of late I’ve noticed 🥴

Huge thanks for the support from @aimlofficial.bsky.social and CIHR for their generous funding support!

Anton van der Vegt Mjaye Mazwi @karinv.bsky.social

Lesley-Anne Farmer Bobby Greer Anna Goldenberg Yvonne Ho @shalmalijoshi.bsky.social Jennie Louise Muhammad Mamdani Abdu Mohamud Lyle Palmer Antonios Peperidis Stephen Pfohl Mandy Rickard Carolyn Semmler @kdpsingh.bsky.social Devin Singh Seyi Soremekun @lanatikhomirov.bsky.social

Super grateful to our amazing steering team, our patient/consumer partners, our partners at the Aboriginal Health Unit at Women’s and Children’s. 🙏🏻

@unityofvirtue.bsky.social Judy Gichoya Mark Sendak Lauren Erdman @istedman.bsky.social Lauren Oakden-Rayner Ismail Akrout James Anderson

So reach out to me and @xiaoliu.bsky.social if you want to get involved with #CANAIRI to build the practices around translational trials for better AI translation!

We propose that ethical governance for health institutions should be grounded in these local evaluations (not just AI vibes 😎) to ensure that when we say a tool ‘works,’ it means it works for US, for OUR patients, for OUR staff, and we have the evidence to say that.

What does this look like?

It will be different for each tool, depending on many things including how much works has been done before on similar tools, how different the local context is, etc.

How do we decide? That’s what we want to figure out, and we need your help!

Fairness evaluations, human factors, cognitive science, patient engagement, environmental considerations (+++ to this one!), economics, and more ➡️ taking this global perspective from the get-go we think will reduce wasteful translation and optimize the benefit!

Many know this already. But we can be doing better with how silent trials are practiced. It’s not just about the model - so we introduce ‘translational trial’ to signal the need for a more holistic evaluation during this silent stage, recognizing that AI is a sociotechnical tool